Amyloid-Beta Precursor Protein (APP) plays a central role in Alzheimer's Disease and dementia. APP is a transmembrane protein found in neural tissue. It is cleaved by enzymes into smaller fragments, including amyloid-beta (Aβ) peptides. Accumulation of Aβ peptides forms plaques, a hallmark of Alzheimer's pathology. These plaques disrupt cell communication and trigger inflammatory responses, contributing to neurodegeneration. Mutations in the APP gene can increase the production of Aβ, leading to early-onset familial Alzheimer's. Understanding APP's function and its cleavage pathways is crucial for developing therapeutic strategies to prevent or reduce amyloid plaque formation, potentially altering the course of Alzheimer's disease.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China